Living with a high-grade glioma: A qualitative study of patients' experiences and care needs
Wendy Sterckx(KU Leuven), Bernadette Dierckx de Casterlé(KU Leuven), Marleen Decruyenaere(KU Leuven), Annemarie Coolbrandt(KU Leuven), Steven De Vleeschouwer(KU Leuven), Paul M. Clément(Universitair Ziekenhuis Leuven), Anne Mees(KU Leuven), Sonja Borgenon(KU Leuven)
Cited by 61
Related Papers
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
|The Lancet Oncology|2016|504